Arab International Medical Holding Company “Tibya” CEO Alaa Ahmed Abdul Majeed Amin said on Sunday that the Capital Market Authority’s approval on the company’s request to register its shares and offer 5 million shares, 25% of “medical” shares with a capital of 200 million riyals in the parallel market “Nomu”, represents the beginning of an important stage in the history and career of the company.
The company implements healthcare projects in the Kingdom and has the main weapons: Al-Faisaliah Medical Systems Company and International Medical Supplies Company, as well as its joint investment with Philips, according to a statement.
The Capital Market Authority has decided to offer 25% of the “medical” shares in the parallel market “Nomu”, and the offer will be limited to the categories of qualified investors provided for in the list of terms used in the regulations and rules of the Capital Authority of market.
The proposed offer will be distributed in the parallel market in two tranches, the first of non-private qualified investors, and they will initially be allotted 100% of the shares, provided that the final allotment takes place after the end of the subscription period for qualified investors (individuals), where their percentage assigned can be reduced, in based on what the financial advisor for the offer, in coordination with the company, sees up to 80% of the shares offered, equal to 4 million shares as a minimum of the shares offered.
The second tranche will be reserved for qualified investors (individuals) and they will be assigned 20% of the shares, equal to one million shares.
The book creation period for non-individual qualified investors begins on Sunday 30 January 2022 and runs until the end of Thursday 3 February 2022.
The subscription for Qualified Individual Investors begins Wednesday 9 February 2022 and will run until the end of Monday 14 February 2022.
Read More About: Business News